RETEVMO

Drug Lilly USA, LLC
Total Payments
$1.1M
Transactions
5,166
Doctors
2,685
Companies
3

Payment Trends by Year

Year Amount Transactions Doctors
2024 $122,792 345 283
2023 $375,085 2,324 1,418
2022 $539,935 1,647 819
2021 $23,457 611 466
2020 $4,482 239 219

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $776,288 374 72.8%
Consulting Fee $121,863 50 11.4%
Food and Beverage $120,081 4,298 11.3%
Travel and Lodging $25,363 253 2.4%
Education $22,158 191 2.1%

Top Doctors Receiving Payments for RETEVMO — Page 104

Doctor Specialty Location Total Records
Shane Betman Hematology New York, NY $13.13 1
, M.D Hematology & Oncology Portsmouth, OH $13.11 1
, M.D Hematology & Oncology Portsmouth, OH $13.11 1
Aileen Rodriguez Family Miami, FL $13.10 1
, MD, PHD Specialist Manteca, CA $13.08 1
, MD Medical Oncology Brooklyn, NY $13.07 1
, PA-C Medical Mcallen, TX $13.05 1
, M.D Endocrinology, Diabetes & Metabolism West Valley City, UT $13.05 1
, NP Acute Care Mount Carmel, IL $13.01 1
, MD Hematology & Oncology Bryn Mawr, PA $13.00 1
, PA-C Medical Bryn Mawr, PA $13.00 1
, CRNP Adult Health Bryn Mawr, PA $13.00 1
, MD, MPH Hematology & Oncology Bryn Mawr, PA $13.00 1
, APRN-BC Adult Health Knoxville, TN $12.98 1
, MD Hematology & Oncology Lenoir City, TN $12.98 1
, M.D Medical Oncology San Diego, CA $12.96 1
, M.D Hematology & Oncology Staten Island, NY $12.91 1
, M.D Hematology & Oncology Denton, TX $12.91 1
, MD Radiation Oncology Antioch, CA $12.90 1
, M.D Internal Medicine San Francisco, CA $12.87 1
, NP Nurse Practitioner Niles, IL $12.85 1
, MD Hematology & Oncology Niles, IL $12.85 1
, PA Physician Assistant Sandy, UT $12.85 1
, MD Endocrinology, Diabetes & Metabolism Sandy, UT $12.85 1
, M.D Otolaryngology Saint Louis, MO $12.84 1

About RETEVMO

RETEVMO is a drug associated with $1.1M in payments to 2,685 healthcare providers, recorded across 5,166 transactions in the CMS Open Payments database. The primary manufacturer is Lilly USA, LLC.

Payment data is available from 2020 to 2024. In 2024, $122,792 was paid across 345 transactions to 283 doctors.

The most common payment nature for RETEVMO is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($776,288, 72.8% of total).